$ENTA

$12.00 +$0.36 (3.09%) Close

$ENTA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$ENTA Management Team

Dr. Bruce Carter

Independent Non-Executive Chairman of the Board

Age 82

Compensation $158.8K USD

Sex Male

Dr. Jay Luly

President

Chief Executive Officer

Director

Age 69

Compensation $2.770M USD

Sex Male

Dr. Yat Sun Or

Chief Scientific Officer

Age 73

Compensation $1.294M USD

Sex Male

Dr. Tara Kieffer

Chief Product Strategy Officer

Age 48

Compensation $2.042M USD

Sex Female

Mr. Brendan Luu

Chief Business Officer

Age 51

Compensation $2.578M USD

Sex Male

Mr. Harry Trout

Interim Principal Financial Officer

Age 57

Compensation -

Sex Male

Ms. Kathleen Capps

Interim Principal Accounting Officer

Age 41

Compensation -

Sex Female

Mr. Scott Rottinghaus

Chief Medical Officer

Age 52

Compensation $1.343M USD

Sex Male

Mr. Matthew Kowalsky

Chief Legal Officer and Corporate Secretary

Age 53

Compensation $1.473M USD

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Bruce Carter Independent Non-Executive Chairman of the Board	82	$158.8K USD	Male
Dr. Jay Luly President Chief Executive Officer Director	69	$2.770M USD	Male
Dr. Yat Sun Or Chief Scientific Officer	73	$1.294M USD	Male
Dr. Tara Kieffer Chief Product Strategy Officer	48	$2.042M USD	Female
Mr. Brendan Luu Chief Business Officer	51	$2.578M USD	Male
Mr. Harry Trout Interim Principal Financial Officer	57	-	Male
Ms. Kathleen Capps Interim Principal Accounting Officer	41	-	Female
Mr. Scott Rottinghaus Chief Medical Officer	52	$1.343M USD	Male
Mr. Matthew Kowalsky Chief Legal Officer and Corporate Secretary	53	$1.473M USD	Male

Board of Directors

From the proxy statement filed Jan 26, 2026

Directors

serving now

Independent

6 of 7

stated in the proxy

Average tenure

11.6 years

from year joined

CEO also chairs the board

Bruce L.A. Carter

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Bruce L.A. Carter Board chair	82	2013 13 years	Independent	Compensation	None stated	Not stated
Jay R. Luly CEO	69	2003 23 years	Not independent	None stated	None stated	Paid as CEO
Yujiro S. Hata	51	2021 5 years	Independent	Compensation	None stated	$123,832
Kristine Peterson	66	2017 9 years	Independent	Compensation · Chair	Immunocore, plc, ArriVent BioPharma, Inc.	$131,332
Terry C. Vance	69	2011 15 years	Independent	Nominating and Corporate Governance · Chair	None stated	$138,832
Mark G. Foletta	65	2020 6 years	Independent	Audit · Chair	DexCom, Inc., AMN Healthcare Services, Inc.	$136,332
Lesley Russell	65	2016 10 years	Independent	Audit	Imugene Limited, Chimeric Therapeutics Limited	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Jan 26, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$ENTA Management Team

Dr. Bruce Carter

Dr. Jay Luly

Dr. Yat Sun Or

Dr. Tara Kieffer

Mr. Brendan Luu

Mr. Harry Trout

Ms. Kathleen Capps

Mr. Scott Rottinghaus

Mr. Matthew Kowalsky

Board of Directors

Related-party transactions

No related-party transactions disclosed